US Patent Issued to Medimmune on Aug. 19 for "Antibodies to ticagrelor and methods of use" (British, Swedish Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,768, issued on Aug. 19, was assigned to Medimmune Ltd. (Cambridge, Great Britain).

"Antibodies to ticagrelor and methods of use" was invented by Andrew Buchanan (Cambridge, Great Britain), Sven Nylander (Sodertalje, Sweden), Mark Penney (Cambridge, Great Britain), Philip Newton (Cambridge, Great Britain), Feenagh Keyes (Cambridge, Great Britain) and Tord Inghardt (Sodertalje, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure generally provides antibodies and antigen binding fragments of antibodies that bind ticagrelor and metabolites of ticagrelor. The disclosure also provides compositions comprising the antibodies, nucleic acid m...